James Ludwick is an expert in the field of Otolaryngology (ENT). He went to Baylor College of Medicine. Doctor James J. Ludwick, MD is a published doctor. He published 3 publications, including: 'The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.' He is registered with Medicare.
NPI NUMBER | 1093712085 | |
NPPES Provider LastName | LUDWICK | |
NPPES Provider FirstName | JAMES | |
NPPES Provider ZIPCode | 770822787 | |
NPPES Provider State | TX | |
Specialty Description | Otolaryngology | |
Total Claim Count | 157.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1093712085 |
Last Name Of The Provider | LUDWICK |
First Name Of The Provider | JAMES |
View All |
Dr. Stephanie K. Cordes, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. David Cuthbertson, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Wojciech K. Mydlarz, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |